These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27995049)

  • 1. Annexin A3 Knockdown Suppresses Lung Adenocarcinoma.
    Liu YF; Liu QQ; Zhang YH; Qiu JH
    Anal Cell Pathol (Amst); 2016; 2016():4131403. PubMed ID: 27995049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.
    Du R; Liu B; Zhou L; Wang D; He X; Xu X; Zhang L; Niu C; Liu S
    Cell Death Dis; 2018 Jan; 9(2):126. PubMed ID: 29374148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.
    Xu R; Yin J; Zhang Y; Zhang S
    J Cell Biochem; 2019 Sep; 120(9):14585-14593. PubMed ID: 30998268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.
    Wang L; Li X; Ren Y; Geng H; Zhang Q; Cao L; Meng Z; Wu X; Xu M; Xu K
    Cancer Sci; 2019 May; 110(5):1609-1620. PubMed ID: 30868675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis
    Guo C; Li N; Dong C; Wang L; Li Z; Liu Q; Ma Q; Greenaway FT; Tian Y; Hao L; Liu S; Sun MZ
    J Adv Res; 2021 May; 30():85-102. PubMed ID: 34026289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
    Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
    J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
    Kim JY; Jung EJ; Park HJ; Lee JH; Song EJ; Kwag SJ; Park JH; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC
    Clin Breast Cancer; 2018 Aug; 18(4):e713-e719. PubMed ID: 29217453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GBX2, as a tumor promoter in lung adenocarcinoma, enhances cells viability, invasion and migration by regulating the AKT/ERK signaling pathway.
    Wang Y; Hui J; Li R; Fu Q; Yang P; Xiao Y; Hui J
    J Gene Med; 2020 Feb; 22(2):e3147. PubMed ID: 31758726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.
    Wei S; Zhang ZY; Fu SL; Xie JG; Liu XS; Xu YJ; Zhao JP; Xiong WN
    Cell Death Dis; 2016 Sep; 7(9):e2388. PubMed ID: 27685632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
    Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
    Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.
    Pan QZ; Pan K; Weng DS; Zhao JJ; Zhang XF; Wang DD; Lv L; Jiang SS; Zheng HX; Xia JC
    Mol Carcinog; 2015 Aug; 54(8):598-607. PubMed ID: 24375474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin.
    Mo D; Yang D; Xiao X; Sun R; Huang L; Xu J
    Biotechnol Lett; 2017 May; 39(5):701-710. PubMed ID: 28120164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of KCNJ4 correlates with cancer progression and unfavorable prognosis in lung adenocarcinoma.
    Wu XY; Yu XY
    J Biochem Mol Toxicol; 2019 Apr; 33(4):e22270. PubMed ID: 30512237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANXA3 deletion inhibits the resistance of lung cancer cells to oxaliplatin.
    Jin YF; Huang YT; Chen PF
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3741-3748. PubMed ID: 32329851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial Annexin A3 promoted the development of melanoma via activation of hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway.
    Xu B; Zhang X; Gao Y; Song J; Shi B
    J Clin Lab Anal; 2021 Feb; 35(2):e23622. PubMed ID: 33118214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
    Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
    Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells.
    Wu KC; Yang ST; Hsia TC; Yang JS; Chiou SM; Lu CC; Wu RS; Chung JG
    Anticancer Res; 2012 Nov; 32(11):4833-42. PubMed ID: 23155249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth.
    Wang K; Li J
    Oncotarget; 2016 Dec; 7(52):86972-86984. PubMed ID: 27894078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling.
    Kake S; Usui T; Ohama T; Yamawaki H; Sato K
    Oncol Rep; 2017 Feb; 37(2):1100-1106. PubMed ID: 28075459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of Livin inhibits tumorigenesis and metastasis via VEGF and MMPs pathway in lung cancer.
    Lin X; Li HR; Lin XF; Yu ME; Tu XW; Hua ZD; Lin M; Xu NL; Han LL; Chen YS
    Int J Oncol; 2015 Aug; 47(2):657-67. PubMed ID: 26094984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.